Tillie Aesthetics Revenue
Medical Practices • 
Blaine, Minnesota, United States • 1-10 Employees
$
Tillie Aesthetics revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Medical Practices industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Key Contact at Tillie Aesthetics
Royce Pavelka
Owner
Company overview
| Headquarters | 11820 Ulysses St NE, #100, Blaine, Minnesota 55434, US |
| Website | |
| NAICS | 62 |
| Keywords | Botox, Medical Aesthetics, Iv Therapy, Dermal Filler, Neurotoxins |
| Founded | 2024 |
| Employees | 1-10 |
About Tillie Aesthetics
Botox (neurotoxins), Fillers, and IV therapy Medical aesthetics made approachable and convenient. If you have ever had interest in learning more about how medical aesthetics work or have had questions about this growing industry, Tillie Aesthetics is for you. Rooted in a rich history of hospital practice and nursing education, Tillie Aesthetics aims to demystify and elevate medical aesthetics for everyone.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Founder/Owner
Funding Data
Tillie Aesthetics has never raised funding before.
France
United KingdomFrequently asked questions
Tillie Aesthetics is located in Blaine, Minnesota, US.
Tillie Aesthetics generates an estimated annual revenue of $85,555. This revenue figure reflects the company's market position and business performance in its industry.
Tillie Aesthetics has an estimated valuation of $273,776. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
Tillie Aesthetics was founded in 2024, making it 2 years old. The company has established itself as a significant player in its industry over this time.
Tillie Aesthetics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
